Rapp Kristi Isaac, Jack Leonard, Wilson Candice, Hayes Sandra Carr, Post Robert, McKnight Ellen, Malveaux Floyd
1 Xavier University of Louisiana College of Pharmacy, New Orleans, LA, USA.
2 Tougaloo College, Tougaloo, MS, USA.
Health Promot Pract. 2018 Mar;19(2):233-239. doi: 10.1177/1524839917740126. Epub 2017 Nov 22.
Pediatric asthma disproportionately affects low-income and minority children. The HEAL (Head-Off Environmental Asthma in Louisiana), Phase II Project was a collaborative effort with a primary focus to improve pediatric asthma management in New Orleans, Louisiana. The purpose of this article is to report clinical outcomes captured at baseline and 12-month follow-up.
HEAL (Head-off Environmental Asthma in Louisiana), Phase II was a pre-post intervention study that enrolled children ages 2 to 18 years of age with a diagnosis of asthma to receive asthma education within the clinic setting. Enrollees received an asthma education intervention, an environmental evaluation, and a 12-month follow-up session. Endpoints included symptom days, level of asthma control, asthma exacerbations, emergency room visits, hospitalizations, and missed school days.
The majority of participants were aged 5 years and older, male, Black, and persistent asthmatics. Emergency room visits decreased from 41% to 20% ( p < .001). Improvements in coughing (83% to 62%, p < .001), wheezing (50% to 26%, p < .001), and chest tightness (29% to 18%, p < .001) were also seen.
The novel intervention was associated with improved asthma outcomes among pediatric patients receiving care at the clinical sites in the Greater New Orleans area.
小儿哮喘对低收入和少数族裔儿童的影响尤为严重。“路易斯安那州预防环境性哮喘(HEAL)”二期项目是一项合作项目,主要致力于改善路易斯安那州新奥尔良市的小儿哮喘管理。本文旨在报告基线和12个月随访时的临床结果。
“路易斯安那州预防环境性哮喘(HEAL)”二期项目是一项干预前后对照研究,纳入了年龄在2至18岁、诊断为哮喘的儿童,在诊所环境中接受哮喘教育。参与者接受了哮喘教育干预、环境评估和为期12个月的随访。观察指标包括症状天数、哮喘控制水平、哮喘发作、急诊就诊、住院和缺课天数。
大多数参与者年龄在5岁及以上,为男性、黑人,且患有持续性哮喘。急诊就诊率从41%降至20%(p < 0.001)。咳嗽(从83%降至62%,p < 0.001)、喘息(从50%降至26%,p < 0.001)和胸闷(从29%降至18%,p < 0.001)也有所改善。
在大新奥尔良地区临床机构接受治疗的小儿患者中,这种新型干预措施与改善哮喘结局相关。